Molecular Vision (MVL) is a CLIA-certified medical diagnostic laboratory that provides state-of-the-art genetic testing for clients worldwide. Our roots stem from the Casey Eye Institute, at the Oregon Health and Science University (OHSU), where our Director and team of lab technicians and bioinformatics scientists developed the most comprehensive test panel for inherited retinal dystrophies.
MVL is committed to developing unique testing methods that improve our ability to detect new disease genes and novel mutation mechanisms. We are actively engaged with numerous research collaborators and we are continuously improving our testing menu to incorporate our latest findings. For example, because of our research on the founder Ashkenazi Jewish mutations and RPGR ORF15 sequencing, our MVL Vision Panel now includes NGS gel analysis testing of large founder deletions in CACNA2D4, CLN3, MAK, and TRPM1, as well as RPGR ORF15 sequencing. By offering these tests for every patient, we now offer the most comprehensive testing service for IRD.